Mandate

EQT – sale of Com Hem

July 19, 2006

EQT has signed an agreement with Carlyle Group and Providence Equity Partners for the sale of Com Hem. The acquisition provides Carlyle Group and Providence Equity good conditions for growth and also creates a good platform for future business in the Swedish and Norwegian market. The sale of Com hem is estimated to be worth approximately EUR 1 billion.

Vinge represented EQT and representatives from Vinge included Frederik von Baumgarten, Mattias Schömer, Olle Rislund, Peter Forsberg, David Aversten, Niclas Bergström and Anna Möller.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025